GSK plc (LON:GSK) Receives GBX 1,842.50 Average Price Target from Brokerages

Shares of GSK plc (LON:GSK) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is GBX 1,842.50 ($23.40).

A number of research firms recently commented on GSK. Shore Capital reissued a “buy” rating on shares of GSK in a research note on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,850 ($23.50) price objective on shares of GSK in a research report on Tuesday, September 3rd. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 1,820 ($23.12) price objective on shares of GSK in a report on Tuesday, September 10th.

Insider Activity at GSK

In other news, insider Jonathan Symonds acquired 7,150 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were purchased at an average price of GBX 1,394 ($17.71) per share, for a total transaction of £99,671 ($126,598.50). Also, insider Elizabeth (Liz) McKee Anderson bought 446 shares of the company’s stock in a transaction dated Monday, September 23rd. The shares were purchased at an average price of GBX 2,051 ($26.05) per share, with a total value of £9,147.46 ($11,618.77). Insiders purchased 7,604 shares of company stock worth $10,893,038 in the last ninety days. 1.61% of the stock is owned by company insiders.

GSK Price Performance

Shares of LON:GSK opened at GBX 1,335.50 ($16.96) on Monday. The company’s fifty day moving average price is GBX 1,437.76 and its 200-day moving average price is GBX 1,550.44. The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73. The firm has a market capitalization of £54.49 billion, a price-to-earnings ratio of 1,182.59, a PEG ratio of 1.24 and a beta of 0.31. GSK has a one year low of GBX 1,282.50 ($16.29) and a one year high of GBX 1,823.50 ($23.16).

GSK Announces Dividend

The business also recently announced a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be paid a GBX 15 ($0.19) dividend. This represents a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, November 14th. GSK’s dividend payout ratio (DPR) is presently 5,309.73%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.